Lakefront Biotherapeutics - American Depositary Shares (LKFT)
33.45
-0.11 (-0.33%)
NASDAQ · Last Trade: Nov 7th, 5:54 AM EST
Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline
Gilead Sciences, Inc. (Nasdaq: GILD) and Lakefront Biotherapeutics NV (Euronext & Nasdaq: LKFT) today announced the successful completion of the previously announced acquisition of Ouro Medicines to advance T cell engager therapies for autoimmune diseases.
By Gilead Sciences, Inc. · Via Business Wire · June 4, 2026